Chronic graft-versus-host disease manifesting as polymyositis: An uncommon presentation

Bone Marrow Transplantation

Volumn 30, Issue 8, 2002, Pages 543-546

  Couriel, D R ^a   Beguelin, G Z ^a   Giralt, S ^a   De Lima, M ^a   Hosing, C ^a   Kharfan Dabaja, M A ^a   Anagnostopoulos, A ^a   Champlin, R ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Allogeneic bone marrow peripheral stem cell transplantation; GVHD; GVHD associated polymyositis; Tacrolimus

Indexed keywords

ALANINE AMINOTRANSFERASE; BUSULFAN; CREATINE KINASE; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; ETOPOSIDE; FRUCTOSE BISPHOSPHATE ALDOLASE; HLA DR ANTIGEN; HYDROXYUREA; INTERFERON; METHYLPREDNISOLONE; STEROID; TACROLIMUS;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ARTICLE; CASE REPORT; CHRONIC MYELOID LEUKEMIA; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; ELECTROMYOGRAPHY; FEMALE; GENETIC ASSOCIATION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IDIOPATHIC DISEASE; IMMUNOSUPPRESSIVE TREATMENT; MALE; MEDICAL DECISION MAKING; MEDICAL LITERATURE; MUSCLE BIOPSY; MUSCLE DISEASE; MUSCLE WEAKNESS; MYALGIA; POLYMYOSITIS; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; RISK ASSESSMENT; WHOLE BODY RADIATION;

ADULT; CHRONIC DISEASE; CYCLOSPORINE; FEMALE; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; POLYMYOSITIS; TACROLIMUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0036810396     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1703711     Document Type: Article

References (32)

1. Ferrara JL, Deeg HJ. Graft-versus-host disease. New Engl J Med 1991; 324: 667-674.
2. Sullivan KM, Shulman HM, Storb R et at. Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. Blood 1981; 57: 267-276.
3. Vogelsang GB, Wagner JE. Graft-versus-host disease. Hematol Oncol Clin North Am 1990; 4: 625-640.
4. Korngold R, Sprent J. T-cell subsets and graft-versus-host disease. Transplantation 1987; 44: 335-339.
5. Diamond D, Chang K, Jenkins K, Forman S. Immunohistochemical analysis of T cell phenotypes in patients with graft-versus-host disease following allogeneic bone marrow transplantation. Transplantation 1995; 59: 1436-1444.
6. Chosidow O, Bagot M, Vernant J-P et al. Sclerodermatous chronic graft-versus-host disease. J Am Acad Dermatol 1992; 26: 49-55.
7. Ameen M, Russell-Jones R. Macroscopic and microscopic mucinosis in chronic sclerodermoid graft-versus-host disease. Br J Dermatol 2000; 142: 529-532.
8. Lawley TJ, Peck GL, Moutsopoulos HM et al. Scleroderma, Sjogren-like syndrome, and chronic graft-versus-host disease. Ann Intern Med 1977; 87: 707-709.
9. Rocha EM, Pelegrino FSA, De Paiva CS et al. GVHD dry eyes treated with autologous serum tears. Bone Marrow Transplant 2000; 25: 1101-1103.
10. Rouquette-Gally AM, Boyeldieu D, Gluckman E et al. Autoimmunity in 28 patients after allogeneic bone marrow transplantation: comparison with Sjogren syndrome and scleroderma. Br J Haematol 1987; 66: 45-47.
11. Parker P, Chao NJ, Ben-Ezra J et al. Polymyositis as a manifestation of chronic graft-versus-host disease. Medicine 1996; 75: 279-285.
12. Parker P, Openshaw H, Forman SJ. Myositis associated with graft-versus-host disease. Curr Opin Rheumatol 1997; 9: 513-519.
13. Prussick R, Brain MC, Walker IR, Sauder DN. Polymyositis: a manifestation of chronic graft-versus-host disease. J Am Acad Dermatol 1991; 25: 560-562.
14. Leano AM, Miller K, White AC. Chronic graft-versus-host disease-related polymyositis as a cause of respiratory failure following allogeneic bone marrow transplant. Bone Marrow Transplant 2000; 26: 1117-1120.
15. Biju G, Debashis D, Mammen C et al. Polymyositis - an unusual manifestation of chronic GVHD. Rheumatol Int 2001; 20: 169-170.
16. Anderson B, Young V, Kean W et al. Polymyositis in chronic GVHD. Arch Neurol 1982; 39: 188-190.
17. Nelson K, McQuillen M. Neurologic complications of GVHD. Neurol Clin 1988; 6: 389-403.
18. Urbano-Marquez A, Estruch R, Grau JM et al. Inflammatory myopathy associated with chronic GVHD. Neurology 1986; 36: 1091-1093.
19. Ascensao J, Mascarenhas RB, Mittleman A, Ahmed T. Case report: acute polymyositis in a patient with chronic GVHD. Med Oncol Tumor Pharmacother 1992; 9: 149-150.
20. Silverstein L, Davies A, Kelsey S et al. Myositis, polyserositis with a large pericardial effusion and constrictive pericarditis as manifestations of chronic GVHD after non-myeloablative peripheral stem cell transplantation and subsequent donor lymphocyte infusion. Bone Marrow Transplant 2001; 27: 231-233.
21. Reyes M, Noronha P, Thomas W, Heredia R. Myositis of chronic GVHD. Neurology 1983; 33: 1222-1224.
22. Pier N, Dubowitz V. Chronic GVHD presenting with polymyositis. Br Med J 1983; 286: 2024.
23. Tse S, Saunders EF, Silverman E et al. Myasthenia gravis and polymyositis as manifestations of chronic GVHD. Bone Marrow Transplant 1999; 23: 397-399.
24. Blanche P, Dreyfus F, Sicard D. Polymyositis and chronic GVHD: efficacy of intravenous gammaglobulin and methotrexate. Clin Exp Rheumatol 1995; 13: 377-379.
25. Slatkin NE, Sheibani K, Forman SJ et al. Myositis as the mayor manifestation of chronic GVHD. Neurology 1987; 205 (Suppl.): 183.
26. Adams C, August CS, Maguire H, Sladky JT. Neuromuscular complications of bone marrow transplantation. Pediatr Neurol 1995; 12: 58-61.
27. Hanslik T, Jaccard A, Guillon JM et al. Polymyositis and chronic graft-versus-host disease: efficacy of intravenous gammaglobulin. J Am Acad Dermatol 1993; 28: 492-493.
28. Oddis CV, Sciurba FC, Elmagd KA, Starzl TE: Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 1999; 353: 1762-1763.
29. Love LA, Leff RL, Fraser DD et al. A new approach to the useful classification of idiopathic inflammatory myopathy: myositis specific autoantibodies define homogeneous patient groups. Medicine 1991; 70: 360-374.
30. Targoff IN. Immune manifestations of inflammatory muscle diseases. Rh Dis Clin North Am 1994; 20: 857-880.
31. Goldstein R, Duvic M, Targoff IN et al. HLA-D region genes associated with autoantibody responses to histidyl-transfer RNA synthetase (Jo-1) and other translation-related factors in myositis. Arthritis Rheum 1990; 33: 1240-1248.
32. Jacobson P, Uberti J, Davis W, Ratantharathorn V. Tacrolimus: a new agent for the prevention of GVHD in hematopoietic stem cell transplantation. Bone Marrow Transplant 1998; 22: 217-225.